BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 17133616)

  • 1. Survey of medication adherence in patients with schizophrenia--Korean ADHES data.
    Kim SW; Yoon JS; Choi SK
    Hum Psychopharmacol; 2006 Dec; 21(8):533-7. PubMed ID: 17133616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial compliance with antipsychotic medication is common in patients with schizophrenia.
    Rummel-Kluge C; Schuster T; Peters S; Kissling W
    Aust N Z J Psychiatry; 2008 May; 42(5):382-8. PubMed ID: 18473256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment adherence in schizophrenia. A comparison between patient's, relative's and psychiatrist's opinions].
    Giner J; Cañas F; Olivares JM; Rodriguez A; Burón JA; Rodríguez-Morales A; Roca M
    Actas Esp Psiquiatr; 2006; 34(6):386-92. PubMed ID: 17117335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic alliance, a stake in schizophrenia].
    Charpentier A; Goudemand M; Thomas P
    Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Assessment of therapeutic adherence using questionnaires in patients with schizophrenia].
    István B; Agnes M
    Psychiatr Hung; 2006; 21(6):430-6. PubMed ID: 17438660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.
    Velligan DI; Weiden PJ; Sajatovic M; Scott J; Carpenter D; Ross R; Docherty JP;
    J Clin Psychiatry; 2009; 70 Suppl 4():1-46; quiz 47-8. PubMed ID: 19686636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychiatrists' awareness of partial- and non-adherence to antipsychotic medication in schizophrenia: results from the Australian ADHES survey.
    Kulkarni J; Reeve-Parker K
    Australas Psychiatry; 2015 Jun; 23(3):258-64. PubMed ID: 25783668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Compliance in the treatment of schizophrenia--project ADHES (the renewed results)].
    Chadzyńska M; Meder J; Tyszkowska M
    Psychiatr Pol; 2008; 42(4):561-70. PubMed ID: 19189600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of adherence problems in patients with serious and persistent mental illness: recommendations from the Expert Consensus Guidelines.
    Velligan DI; Weiden PJ; Sajatovic M; Scott J; Carpenter D; Ross R; Docherty JP
    J Psychiatr Pract; 2010 Jan; 16(1):34-45. PubMed ID: 20098229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schizophrenia: attitudes of patients and professional carers towards the illness and antipsychotic medication.
    Rettenbacher MA; Burns T; Kemmler G; Fleischhacker WW
    Pharmacopsychiatry; 2004 May; 37(3):103-9. PubMed ID: 15138893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of open access to atypical antipsychotics for the treatment of schizophrenia and bipolar disorder: a European perspective.
    Altamura AC; Armadoros D; Jaeger M; Kernish R; Locklear J; Volz HP
    Curr Med Res Opin; 2008 Aug; 24(8):2271-82. PubMed ID: 18588748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prototype approach toward antipsychotic medication adherence in schizophrenia.
    Freudenreich O; Tranulis C
    Harv Rev Psychiatry; 2009; 17(1):35-40. PubMed ID: 19205965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Course of adherence to medication and quality of life in people with schizophrenia.
    Puschner B; Angermeyer MC; Leese M; Thornicroft G; Schene A; Kikkert M; Burti L; Tansella M; Becker T
    Psychiatry Res; 2009 Feb; 165(3):224-33. PubMed ID: 19155070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to medication and quality of life in people with schizophrenia: results of a European multicenter study.
    Puschner B; Born A; Giessler A; Helm H; Leese M; Bindman JP; Gray RJ; Schene A; Kikkert M; Burti L; Marrella G; Becker T
    J Nerv Ment Dis; 2006 Oct; 194(10):746-52. PubMed ID: 17041286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial compliance in schizophrenia and the impact on patient outcomes.
    Llorca PM
    Psychiatry Res; 2008 Nov; 161(2):235-47. PubMed ID: 18849080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adherence to neuroleptic treatment of schizophrenic patients].
    Blondiaux I; Alagille M; Ginestet D
    Encephale; 1988; 14(6):431-8. PubMed ID: 2906607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schizophrenia through the carers' eyes: results of a European cross-sectional survey.
    Svettini A; Johnson B; Magro C; Saunders J; Jones K; Silk S; Hargarter L; Schreiner A
    J Psychiatr Ment Health Nurs; 2015 Sep; 22(7):472-83. PubMed ID: 25944551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand.
    Maneesakorn S; Robson D; Gournay K; Gray R
    J Clin Nurs; 2007 Jul; 16(7):1302-12. PubMed ID: 17584349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia.
    Byerly M; Fisher R; Whatley K; Holland R; Varghese F; Carmody T; Magouirk B; Rush AJ
    Psychiatry Res; 2005 Feb; 133(2-3):129-33. PubMed ID: 15740989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of clinician awareness of nonadherence using a new structured rating scale.
    Clayton CD; Veach J; Macfadden W; Haskins J; Docherty JP; Lindenmayer JP
    J Psychiatr Pract; 2010 May; 16(3):164-9. PubMed ID: 20485104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.